Open AccessPharmacoeconomic aspects of COVID-19 treatment
Author(s) -
И В Рогова,
Elena A. Zhidkova,
I.A. Popova,
A. V. Zaborovsky,
К. Г. Гуревич
Publication year - 2021
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909/farmakoekonomika.2021.086
Subject(s) - covid-19 , pandemic , coronavirus , health care , healthcare system , process (computing) , clinical trial , risk analysis (engineering) , medicine , business , intensive care medicine , management science , computer science , economic growth , virology , economics , outbreak , infectious disease (medical specialty) , pathology , disease , operating system
The article provides an overview of global trends in various treatment approaches for COVID-19 in terms of pharmacoeconomic effectiveness. Different strategies for managing patients with the new coronavirus infection, separate groups of drugs are considered. The current clinical trials for COVID-19, the main directions, problems and challenges facing the healthcare system are discussed in detail. The aspects of the economic efficiency of various measures to prevent the spread of COVID-19 are presented. A thorough study of the pharmacoeconomic features of the new coronavirus infection will allow to develop effective standards for planning the process of supply for medical organizations in the pandemic.